Kalvista Pharmaceuticals Inc (KALV)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | 2025-06-09 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
7 169
-2.2%
14,50103 951 USD |
7 169 -2.2% | 14,50 | 103 951 USD | |
| 2025-05-27 | 2025-05-23 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 146
-1.9%
11,3124 272 USD |
2 146 -1.9% | 11,31 | 24 272 USD | |
| 2025-05-27 | 2025-05-23 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
1 926
-1.9%
11,3121 782 USD |
1 926 -1.9% | 11,31 | 21 782 USD | |
| 2025-05-23 | 2025-05-22 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
9 999
-3.2%
11,88118 743 USD |
9 999 -3.2% | 11,88 | 118 743 USD | |
| 2025-05-23 | 2025-05-22 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
2 317
-2.3%
11,8827 516 USD |
2 317 -2.3% | 11,88 | 27 516 USD | |
| 2025-05-23 | 2025-05-22 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 689
-2.4%
11,8831 933 USD |
2 689 -2.4% | 11,88 | 31 933 USD | |
| 2025-05-20 | 2025-05-19 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
3 808
-1.3%
11,8445 097 USD |
3 808 -1.3% | 11,84 | 45 097 USD | |
| 2025-05-20 | 2025-05-19 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 776
-2.5%
11,8432 876 USD |
2 776 -2.5% | 11,84 | 32 876 USD | |
| 2025-05-20 | 2025-05-19 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
2 600
-2.6%
11,8430 791 USD |
2 600 -2.6% | 11,84 | 30 791 USD | |
| 2025-04-11 | 2025-04-09 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
25 000
+0.5%
9,42235 500 USD |
25 000 +0.5% | 9,42 | 235 500 USD | |
| 2025-03-10 | 2025-03-07 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
6 669
-2.3%
11,9779 828 USD |
6 669 -2.3% | 11,97 | 79 828 USD | |
| 2025-02-25 | 2025-02-24 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
2 394
-2.3%
10,0223 988 USD |
2 394 -2.3% | 10,02 | 23 988 USD | |
| 2025-02-25 | 2025-02-24 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
1 918
-2.0%
10,0219 218 USD |
1 918 -2.0% | 10,02 | 19 218 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF DEVELOPMENT OFFICER Dirigeant |
2 601
-2.7%
9,8225 553 USD |
2 601 -2.7% | 9,82 | 25 553 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF EXECUTIVE OFFICER Administrateur exécutif |
5 104
-1.8%
9,8250 143 USD |
5 104 -1.8% | 9,82 | 50 143 USD | |
| 2025-02-19 | 2025-02-18 | V Vente |
CHIEF MEDICAL OFFICER Dirigeant |
3 125
-3.0%
9,8230 701 USD |
3 125 -3.0% | 9,82 | 30 701 USD | |
| 2025-02-14 | 2025-02-13 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
61 700
+1.2%
9,33575 661 USD |
61 700 +1.2% | 9,33 | 575 661 USD | |
| 2025-02-14 | 2025-02-12 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
100 000
+2.0%
9,23923 000 USD |
100 000 +2.0% | 9,23 | 923 000 USD | |
| 2025-02-11 | 2025-02-11 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
26 703
+0.5%
9,18245 134 USD |
26 703 +0.5% | 9,18 | 245 134 USD | |
| 2025-02-11 | 2025-02-10 | A Achat |
Venrock Healthcare Capital Partners III, L.P. Actionnaire important |
4 137
+0.1%
9,1437 812 USD |
4 137 +0.1% | 9,14 | 37 812 USD |